BD Announces FDA Classifications for August 4th Recalls of BD Alaris(TM) System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error

Three Recalls Designated as Class I by FDA; One Designated as Class II FRANKLIN LAKES, N.J., Sept. 21, 2020 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today ... Devices, Product Recall BD , Alaris System, infusion pump
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news